日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction to: Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results from VALOR-HCM

更正:Mavacamten治疗接受室间隔减容术的肥厚型心肌病患者:VALOR-HCM研究第128周结果

Desai, Milind Y; Wolski, Kathy; Owens, Anjali; Geske, Jeffrey B; Saberi, Sara; Wang, Andrew; Sherrid, Mark; Cremer, Paul C; Lakdawala, Neal K; Tower-Rader, Albree; Fermin, David; Naidu, Srihari S; Smedira, Nicholas G; Schaff, Hartzell; Gong, Zhiqun; Mudarris, Lana; Lampl, Kathy; Sehnert, Amy J; Nissen, Steven E

Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM

Mavacamten治疗接受室间隔减容术的肥厚型心肌病患者:VALOR-HCM研究第128周结果

Desai, Milind Y; Wolski, Kathy; Owens, Anjali; Geske, Jeffrey B; Saberi, Sara; Wang, Andrew; Sherrid, Mark; Cremer, Paul C; Lakdawala, Neal K; Tower-Rader, Albree; Fermin, David; Naidu, Srihari S; Smedira, Nicholas G; Schaff, Hartzell; Gong, Zhiqun; Mudarris, Lana; Lampl, Kathy; Sehnert, Amy J; Nissen, Steven E

Cardiopulmonary exercise testing parameters in healthy athletes vs. equally fit individuals with hypertrophic cardiomyopathy

健康运动员与体能水平相当的肥厚型心肌病患者的心肺运动试验参数比较

McHugh, Cliodhna; Gustus, Sarah K; Petek, Bradley J; Schoenike, Mark W; Boyd, Kevin S; Kennett, Jasmine B; VanAtta, Carolyn; Tower-Rader, Albree F; Fifer, Michael A; DiCarli, Marcelo F; Wasfy, Meagan M

Multimodality Imaging Evaluation of Diseases of the Pulmonic Valve and Right Ventricular Outflow Tract for the Adult Cardiologist

成人心脏病学家对肺动脉瓣和右心室流出道疾病的多模态影像评估

Murphy, Seán P; Sultana, Sadia; Zern, Emily K; Tower-Rader, Albree; Churchill, Jessica L; Stefanescu Schmidt, Ada C; Huang, Sihong; Learn, Christopher P; Churchill, Timothy W; DeFaria Yeh, Doreen; Yucel, Evin

Echocardiographic Changes Following Surgical Myectomy in Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy: Insights From the SPIRIT-HCM Study

严重症状性梗阻性肥厚型心肌病患者行外科心肌切除术后超声心动图变化:来自 SPIRIT-HCM 研究的启示

Desai, Milind Y; Szpakowski, Natalie; Tower-Rader, Albree; Bittel, Barb; Fava, Agostina; Ospina, Susan; Xu, Bo; Thamilarasan, Maran; Mentias, Amgad; Smedira, Nicholas G; Popovic, Zoran B

Longitudinal Evaluation of Genetic Hypertrophic Cardiomyopathy Penetrance and Transition to Disease in an Academic Biobank

学术生物样本库中遗传性肥厚型心肌病外显率和疾病转变的纵向评估

Shin, Joseph Y; Small, Aeron M; Blout Zawatsky, Carrie L; Fifer, Michael A; Tower-Rader, Albree; Green, Robert C; Lebo, Matthew; Natarajan, Pradeep

Endothelial Cell-Related Proteins in Plasma Predict Major Adverse Cardiovascular Events and Worsening Heart Failure in Patients With Hypertrophic Cardiomyopathy

血浆中内皮细胞相关蛋白可预测肥厚型心肌病患者的主要不良心血管事件和心力衰竭恶化

Tamura, Shogo; Akita, Keitaro; Fifer, Michael A; Tower-Rader, Albree; Maurer, Mathew S; Shimada, Yuichi J

Comprehensive Proteomics Profiling Identifies Circulating Biomarkers to Distinguish Hypertrophic Cardiomyopathy From Other Cardiomyopathies With Left Ventricular Hypertrophy

全面的蛋白质组学分析可识别循环生物标志物,从而区分肥厚型心肌病与其他伴有左心室肥厚的心肌病

Akita, Keitaro; Maurer, Mathew S; Tower-Rader, Albree; Fifer, Michael A; Shimada, Yuichi J

Prediction of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy using machine learning

利用机器学习预测肥厚型心肌病患者新发房颤

Lu, Ree; Lumish, Heidi S; Hasegawa, Kohei; Maurer, Mathew S; Reilly, Muredach P; Weiner, Shepard D; Tower-Rader, Albree; Fifer, Michael A; Shimada, Yuichi J

Plasma SVEP1 Levels Predict Cardiovascular Events in Hypertrophic Cardiomyopathy Beyond Conventional Clinical Risk Models Including NT-proBNP

血浆SVEP1水平可预测肥厚型心肌病患者的心血管事件,其预测能力优于包括NT-proBNP在内的传统临床风险模型。

Osawa, Itsuki; Akita, Keitaro; Hasegawa, Kohei; Fifer, Michael A; Tower-Rader, Albree; Reilly, Muredach P; Maurer, Mathew S; Stitziel, Nathan O; Javaheri, Ali; Shimada, Yuichi J